Table 2.
Scores at referral and during follow up on state anxiety, depressive symptoms, and general quality of life (QoL) comparing four groups based on referral after abnormal screening program (ASM) or with palpable lump in breast (PL) and high trait anxiety (HTA) or not-high trait anxiety (NHTA)
| Mean scores (SD) | ASM (n = 75) | PL (n = 85) | P value | ||
|---|---|---|---|---|---|
| HTAa | At referral | 6 months | At referral | 6 months | |
| State anxiety | 15.7 (3.4) | 13.1 (3.6) | 15.5 (3.5) | 13.2 (3.6) | NS |
| Depressive symptoms | 15.8 (9.3) | 11.4 (9.3)b | 14.7 (9.6) | 12.3 (8.8)b | NS |
| At referral | 12 months | At referral | 12 months | ||
|---|---|---|---|---|---|
| General QoL | 6.9 (1.4) | 6.9 (1.6) | 6.7 (1.5) | 6.7 (1.3) | NS |
| ASM n = 288 | PL n = 316 | P value | |||
|---|---|---|---|---|---|
| NHTAa | At referral | 6 months | At referral | 6 months | |
| State anxiety | 12.2 (3.9) | 9.7 (3.0)b | 11.6 (3.4) | 9.7 (3.1)b | R 0.047 |
| Depressive symptoms | 7.0 (6.8) | 5.3 (5.6) | 5.2 (5.4) | 4.4 (5.4) | R < 0.001 |
| At referral | 12 months | At referral | 12 months | ||
|---|---|---|---|---|---|
| General QoL | 8.1 (1.4) | 8.0 (1.3) | 8.2 (1.2) | 8.3 (1.2) | NS |
P value <0.05 considered significant. SD standard deviation, NS not significant, R significant difference at referral comparing ASM and PL
aAll values in the HTA groups are significant different compared with NHTA groups (P < 0.001)
bScores significantly changed at 6 months compared with scores at referral